These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 32983456)

  • 21. COVID-19 Pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU.
    Vega ML; Dongilli R; Olaizola G; Colaianni N; Sayat MC; Pisani L; Romagnoli M; Spoladore G; Prediletto I; Montiel G; Nava S
    Pulmonology; 2022; 28(1):13-17. PubMed ID: 34049831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-Flow Nasal Cannula Treatment in Patients with COVID-19 Acute Hypoxemic Respiratory Failure: A Prospective Cohort Study.
    Alshahrani MS; Alshaqaq HM; Alhumaid J; Binammar AA; AlSalem KH; Alghamdi A; Abdulhady A; Yehia M; AlSulaibikh A; Al Jumaan M; Albuli WH; Ibrahim T; Yousef AA; Almubarak Y; Alhazzani W
    Saudi J Med Med Sci; 2021; 9(3):215-222. PubMed ID: 34667467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of High-Flow Nasal Cannula Oxygen Therapy in Patients with Mild Hypercapnia.
    Su L; Zhao Q; Liu T; Xu Y; Li W; Zhang A
    Lung; 2021 Oct; 199(5):447-456. PubMed ID: 34448939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of the use of a high-flow nasal cannula to treat COVID-19 patients and risk factors for failure: a meta-analysis.
    Xu DY; Dai B; Tan W; Zhao HW; Wang W; Kang J
    Ther Adv Respir Dis; 2022; 16():17534666221091931. PubMed ID: 35467449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the Early Combination of Continuous Positive Airway Pressure and High-Flow Nasal Cannula on Mortality and Intubation Rates in Patients With COVID-19 and Acute Respiratory Distress Syndrome. The DUOCOVID Study.
    Teran-Tinedo JR; Gonzalez-Rubio J; Najera A; Lorente-Gonzalez M; Cano-Sanz E; De La Calle-Gil I; Ortega-Fraile MÁ; Carballo-López D; Hernández-Nuñez J; Churruca-Arróspide M; Zevallos-Villegas A; López-Padilla D; Puente-Maestú L; Navarro-Lopez JD; Jimenez-Diaz L; Landete P
    Arch Bronconeumol; 2023 May; 59(5):288-294. PubMed ID: 36797139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure Prediction of High-Flow Nasal Cannula at the Conventional Oxygen Therapy Phase in the Emergency Department.
    Kang Y; Jung HM; Chung SP; Chung HS; Cho Y
    Respiration; 2024 Jun; ():1-8. PubMed ID: 38934166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ROX index as a predictor of high-flow nasal cannula outcome in pneumonia patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis.
    Zhou X; Liu J; Pan J; Xu Z; Xu J
    BMC Pulm Med; 2022 Apr; 22(1):121. PubMed ID: 35365110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of Sequential ROX-Index Score Beyond 12 Hours in Predicting Treatment Failure and Mortality in COVID-19 Patients Receiving Oxygen via High-Flow Nasal Cannula.
    Basoulis D; Avramopoulos P; Aggelara M; Karamanakos G; Voutsinas PM; Karapanou A; Psichogiou M; Samarkos M; Ntziora F; Sipsas NV
    Can Respir J; 2023; 2023():7474564. PubMed ID: 36817550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Flow Nasal Cannula in COVID-19 Patients With Moderate to Severe Respiratory Distress: A Retrospective Analysis.
    Saffarini L; Sabobeh N; Lasfer C; Kazim S
    Cureus; 2024 Jan; 16(1):e52518. PubMed ID: 38371128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study.
    Hu M; Zhou Q; Zheng R; Li X; Ling J; Chen Y; Jia J; Xie C
    BMC Pulm Med; 2020 Dec; 20(1):324. PubMed ID: 33357219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive ventilation and high-flow nasal cannula in patients with acute hypoxemic respiratory failure by covid-19: A retrospective study of the feasibility, safety and outcomes.
    Costa WNDS; Miguel JP; Prado FDS; Lula LHSM; Amarante GAJ; Righetti RF; Yamaguti WP
    Respir Physiol Neurobiol; 2022 Apr; 298():103842. PubMed ID: 35026479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ratio of oxygen saturation index for predicting high-flow nasal cannula outcomes in emergency department for COVID-19 patients with severe hypoxemia: A retrospective study.
    Karam C; Oseili A; Shebbo FM; Fakih M; El-Khatib MF
    Turk J Emerg Med; 2024; 24(1):41-47. PubMed ID: 38343517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. External validation of the HACOR score and ROX index for predicting treatment failure in patients with coronavirus disease 2019 pneumonia managed on high-flow nasal cannula therapy: a multicenter retrospective observational study in Japan.
    Okano H; Yamamoto R; Iwasaki Y; Irimada D; Konno D; Tanaka T; Oishi T; Nawa H; Yano A; Taniguchi H; Otawara M; Matsuoka A; Yamauchi M
    J Intensive Care; 2024 Feb; 12(1):7. PubMed ID: 38360681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of High-Flow Nasal Cannula Oxygen Therapy in Subjects With ARDS: A 1-Year Observational Study.
    Messika J; Ben Ahmed K; Gaudry S; Miguel-Montanes R; Rafat C; Sztrymf B; Dreyfuss D; Ricard JD
    Respir Care; 2015 Feb; 60(2):162-9. PubMed ID: 25371400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diaphragmatic Ultrasound Predictors of High-Flow Nasal Cannula Therapeutic Failure in Critically Ill Patients With SARS-CoV-2 Pneumonia.
    Bruna M; Hidalgo G; Castañeda S; Galvez M; Bravo D; Benitez R; Tobar R; Quevedo J; Rodríguez J; Murua C; Madariaga R; Benavides C; Huilcaman M; Martinez F; Retamal J; Kattan E
    J Ultrasound Med; 2023 Jun; 42(6):1277-1284. PubMed ID: 36444988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes of high-flow nasal cannula in COVID-19 associated postextubation respiratory failure. A single-centre case series.
    Simioli F; Annunziata A; Langella G; Polistina GE; Martino M; Fiorentino G
    Anaesthesiol Intensive Ther; 2020; 52(5):373-376. PubMed ID: 33242934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-Flow Nasal Cannula Therapy in Patients With COVID-19: Predictive Response Factors.
    Raboni SM; Neves VC; Silva RM; Breda GL; Ceregato AC; Broza TP; de Oliveira G; Melo-Diaz LL; Braga CB; Carraro CF; Arroyo NC; Bardy RF; Devetak GF; Ozawa CM; Graf ME; Dias VL; Ducroquet MA; Nunes DP; Sokoloski CS; Petterle RR
    Respir Care; 2022 Nov; 67(11):1443-1451. PubMed ID: 35944966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of High-Flow Nasal Cannula and Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure Due to Severe COVID-19 Pneumonia.
    Nair PR; Haritha D; Behera S; Kayina CA; Maitra S; Anand RK; Ray BR; Soneja M; Subramaniam R; Baidya DK
    Respir Care; 2021 Dec; 66(12):1824-1830. PubMed ID: 34584010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ratio of Oxygen Saturation to Inspired Oxygen, ROX Index, Modified ROX Index to Predict High Flow Cannula Success in COVID-19 Patients: Multicenter Validation Study.
    Ruangsomboon O; Jirathanavichai S; Phanprasert N; Puchongmart C; Boonmee P; Thirawattanasoot N; Dorongthom T; Monsomboon A; Praphruetkit N
    West J Emerg Med; 2023 Apr; 24(3):511-521. PubMed ID: 37278775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of High-Flow Nasal Cannula Use in Subjects With COVID-19 ARDS at High Altitudes: Clinical Presentation and Prognostic Factors.
    Molano-Franco D; Viruez-Soto A; Gomez M; Beltran E; Villabon M; Sosa A; Ortiz L; Orozco E; Hurtado A; Sanchez L; Arias-Reyes C; Soliz J; Masclans JR
    Respir Care; 2023 Jun; 69(1):99-105. PubMed ID: 37311630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.